Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

The mechanism of ceftazidime and cefiderocol hydrolysis by D179Y variants of KPC carbapenemases is similar and involves the formation of a long-lived covalent intermediate

Antimicrobial Agents and Chemotherapy(2024)10.1128/aac.01108-23Source: DataRank Database

The mechanism of ceftazidime and cefiderocol hydrolysis by D179Y variants of KPC carbapenemases is similar and involves the formation of a long-lived covalent intermediate is a research paper published in Antimicrobial Agents and Chemotherapy (2024). On theSindex it has a DataRank of 0. It has been cited 24 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access24 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 3.25)OA: greenTopics (46)IDs (PubMed, PMC, OpenAlex)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (3)

Christina Nnabuife,Timothy Palzkill ORCID,André Birgy ORCID

Live enrichment

PubMed:38259088 PMC:PMC10916376 OpenAlex:https://openalex.org/W4391133210

HHS | NIH | National Institute of Allergy and Infectious Diseases

Grant: AI32956

NIAID NIH HHS

Grant: R56 AI032956

NIAID NIH HHS

Grant: R37 AI032956

NIAID NIH HHS

Grant: R01 AI032956

FWCI

3.25

Citation Percentile

0.9%

Citation Trend

2024

2025

2026

greenLicense: https://doi.org/10.1128/ASMCopyrightv2

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC10916376/pdf/aac.01108-23.pdf

GREENhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10916376

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC10916376/pdf/aac.01108-23.pdf

publisherhttps://journals.asm.org/doi/pdf/10.1128/aac.01108-23

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/10916376

Fields of Study

Antibiotic Resistance in BacteriaAntibiotics Pharmacokinetics and EfficacyDrug Transport and Resistance MechanismsMedicineChemistryCeftazidimeAnti-Bacterial AgentsCefiderocolKlebsiella pneumoniaeHydrolysisBacterial Proteinsbeta-LactamasesDrug CombinationsAzabicyclo CompoundsMicrobial Sensitivity Tests

MeSH Terms

CefiderocolAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasesCeftazidimeDrug CombinationsHydrolysisKlebsiella pneumoniaeMicrobial Sensitivity TestsAzabicyclo Compounds

Keywords

CeftazidimeEnzyme kineticsCeftazidime/avibactamBiologyHydrolysisKineticsChemistryEnzymeBiochemistryActive siteGeneticsPseudomonas aeruginosaBacteriaPhysicsCross-resistanceAntibiotic ResistanceΒ-lactamaseTransient KineticsEnzyme VariantsKpc-31 Β-lactamaseKpc-33 Β-lactamase